CVS Health Corp (NYSE:CVS) Shares Purchased by Sheaff Brock Investment Advisors LLC

Sheaff Brock Investment Advisors LLC boosted its holdings in CVS Health Corp (NYSE:CVS) by 11.2% during the second quarter, Holdings Channel reports. The institutional investor owned 16,489 shares of the pharmacy operator’s stock after buying an additional 1,655 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in CVS Health were worth $898,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of CVS. Capital Investment Advisory Services LLC raised its holdings in shares of CVS Health by 3.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock valued at $277,000 after buying an additional 189 shares during the period. Virginia National Bank raised its holdings in shares of CVS Health by 4.9% during the 1st quarter. Virginia National Bank now owns 4,100 shares of the pharmacy operator’s stock valued at $221,000 after buying an additional 190 shares during the period. Burke & Herbert Bank & Trust Co. raised its holdings in shares of CVS Health by 2.8% during the 1st quarter. Burke & Herbert Bank & Trust Co. now owns 7,466 shares of the pharmacy operator’s stock valued at $402,000 after buying an additional 200 shares during the period. First Command Financial Services Inc. raised its holdings in shares of CVS Health by 16.0% during the 2nd quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock valued at $80,000 after buying an additional 202 shares during the period. Finally, Hudock Capital Group LLC raised its holdings in shares of CVS Health by 54.0% during the 2nd quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 202 shares during the period. 77.18% of the stock is currently owned by hedge funds and other institutional investors.

CVS stock traded down $0.72 during midday trading on Wednesday, hitting $59.13. 311,359 shares of the company’s stock were exchanged, compared to its average volume of 11,224,507. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. CVS Health Corp has a 12-month low of $51.72 and a 12-month high of $82.15. The business has a 50 day moving average of $56.12. The firm has a market capitalization of $77.11 billion, a PE ratio of 8.34, a price-to-earnings-growth ratio of 1.30 and a beta of 0.90.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.70 by $0.19. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same period in the previous year, the business earned $1.69 EPS. The business’s quarterly revenue was up 35.2% on a year-over-year basis. On average, sell-side analysts forecast that CVS Health Corp will post 6.96 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Stockholders of record on Thursday, July 25th were issued a $0.50 dividend. The ex-dividend date was Wednesday, July 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.38%. CVS Health’s dividend payout ratio (DPR) is 28.25%.

Several equities research analysts recently commented on the company. Morgan Stanley reiterated a “buy” rating and set a $74.00 target price on shares of CVS Health in a report on Sunday. Guggenheim assumed coverage on CVS Health in a report on Thursday, April 18th. They set a “buy” rating and a $75.00 target price on the stock. Raymond James dropped their target price on CVS Health from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a report on Thursday, April 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 target price on shares of CVS Health in a report on Wednesday, May 1st. Finally, ValuEngine downgraded CVS Health from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 2nd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $75.14.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Story: How to start trading in the forex market?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.